Cargando…
Mesalazine in the Treatment of Extensive Alopecia Areata: A New Therapeutic Option?
BACKGROUND: Alopecia areata (AA) is a T-lymphocyte-mediated disease that results in alopecia plaques or diffuses alopecia on the scalp and body. Etiologic factors include genetic and autoimmune susceptibility. Treatment modalities are usually considered according to the extent of hair loss and the p...
Autores principales: | Kiszewski, Ana Elisa, Bevilaqua, Mariele, De Abreu, Luciana Boff De |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6029002/ https://www.ncbi.nlm.nih.gov/pubmed/30034187 http://dx.doi.org/10.4103/ijt.ijt_14_18 |
Ejemplares similares
-
Efficacy of mesalazine in children with moderate to severe alopecia areata: case series of 18 patients()
por: Vivian, Analú, et al.
Publicado: (2023) -
Intralesional betamethasone as a therapeutic option for alopecia
areata
por: Melo, Daniel Fernandes, et al.
Publicado: (2018) -
An Updated Review on Current Treatment of Alopecia Areata and Newer Therapeutic Options
por: Malhotra, Karan, et al.
Publicado: (2023) -
Alopecia Areata: Review of Epidemiology, Clinical Features, Pathogenesis, and New Treatment Options
por: Darwin, Evan, et al.
Publicado: (2018) -
Alopecia areata incognita
por: Molina, Luciana, et al.
Publicado: (2011)